Tocqueville Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Tocqueville Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,000	Closed	-$504K	–	801
2018 Q4	$504K	Hold	5,000	–	–	0.01%	554
2018 Q3	$632K	Buy	5,000 +2,000	+67%	+$212K	0.01%	578
2018 Q2	$252K	Buy	+3,000	New	+$220K	﹤0.01%	731
2016 Q4	–	Sell	-4,000	Closed	-$658K	–	861
2016 Q3	$658K	Sell	4,000 -200	-5%	-$31.5K	0.01%	582
2016 Q2	$599K	Sell	4,200 -700	-14%	-$102K	0.01%	599
2016 Q1	$630K	Sell	4,900 -400	-8%	-$47.2K	0.01%	581
2015 Q4	$792K	Sell	5,300 -16,615	-76%	-$2.81M	0.01%	580
2015 Q3	$3.63M	Sell	21,915 -5,435	-20%	-$1.2M	0.05%	341
2015 Q2	$6.6M	Sell	27,350 -4,630	-14%	-$1.23M	0.08%	263
2015 Q1	$9.02M	Buy	31,980 +18,990	+146%	+$4.11M	0.11%	222
2014 Q4	$2.03M	Sell	12,990 -1,720	-12%	-$318K	0.02%	483
2014 Q3	$3.48M	Buy	14,710 +7,690	+110%	+$1.96M	0.04%	338
2014 Q2	$1.66M	Buy	7,020 +1,435	+26%	+$378K	0.02%	497
2014 Q1	$1.84M	Buy	+5,585	New	+$1.88M	0.02%	389

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Tocqueville Asset Management's ICPT Position: Q1 2019 in Review

Tocqueville Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 5,000 shares — an estimated $504K sold.

Tocqueville Asset Management first reported a position in ICPT in Q1 2014 and held it in 14 quarters. The position peaked at $9.02M in Q1 2015. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

Tocqueville Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Tocqueville Asset Management sold 5,000 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $504K.
Tocqueville Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 14 quarters.
Tocqueville Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $9.02M in Q1 2015.
202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on Tocqueville Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.